Rapid diagnosis of germline p53 mutation using the enzyme mismatch cleavage method

Diagnostic Molecular Pathology

Volumn 5, Issue 4, 1996, Pages 265-270

  Giunta, C ^a   Youil, R ^a,e   Venter, D ^b   Chow, C W ^b   Somers, G ^b   Lafferty, A ^c   Kemper, B ^d   Cotton, R G H ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Department of Endocrinology ^*  (Australia)

^d UNIVERSITY OF COLOGNE   (Germany)

^e Avitech Diagnostics Inc   (United States)

Author keywords

Enzyme mismatch cleavage; Germline p53 mutation; Li Fraumeni syndrome

Indexed keywords

ADRENAL CORTEX CARCINOMA; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROECTODERM TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADRENOCORTICAL CARCINOMA; CHILD, PRESCHOOL; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; GENES, P53; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; NEUROECTODERMAL TUMORS; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0029988234     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199612000-00007     Document Type: Article

References (16)

1. Birch J. Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges. Br J Cancer 1992;66:424-6.
2. Cotton RGH. Current method of mutation detection. Mutat Res 1993;258:125-44.
3. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54: 4855-78.
4. Jones MJ, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chrom Cancer 1992;5:89-90.
5. Lane DP. p53 and human cancers. Br Med Bull 1994;50: 582-9.
6. Li F, Fraumeni J. Soft-tissue sarcomas, breast cancer and other neoplasms. Ann Intern Med 1969:71.
7. Li F, Fraumeni J, Mulvihill J, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988;48:5358-62.
8. Malkin D, Li F, Strong L, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
9. Prosser J, Thompson AM, Cranston G, Evans, HJ. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene 1990;5:1573-9.
10. Sambrook J, Fritsch, EF, Maniatis T. Molecular cloning. A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
11. Solaro PC, Birkenkamp K, Pfeiffer P, Kemper B. Endonuclease VII of phage T4 triggers very short patch repair in vitro. J Mol Biol 1993;230:868-77.
12. Stolnzenberg M-C, Brugiers L, Garde M, et al. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family. Oncogene 1994;9:2799-804.
13. Youil R, Kemper B, Cotton RGH. Screening for mutations by enzyme cleavage of mismatch using T4 endonuclease VII. Am J Hum Genet 1993;53(3)(Suppl):Abstr 1257.
14. Youil R, Kemper BW, Cotton RGH. Screening for mutations by enzyme mismatch cleavage using T4 endonuclease VII. Proc Natl Acad Sci 1995;92:87-91.
15. Zambetti GP, Levine AJ. A comparison of the biological activities of wild-type and mutant p53. FASEB J 1993;7:855-65.
16. Youil R, Kemper B, Cotton RGH. Detection of 81 of 81 known mouse β-globin promoter mutations with T4 endonuclease VII-the EMC method. Genomics 1996;32: 431-5.